Transcriptional Regulation of Type 11 17β-Hydroxysteroid Dehydrogenase Expression in Prostate Cancer Cells

Mirja Rotinen (1) , Joaquín Villar (1) , Jon Celay (1) , Irantzu Serrano (1) , Vicente Notario (2) , Ignacio Encío (1)

1 Department of Health Sciences
2 Georgetown University Medical Center

Type 11 Hydroxysteroid (17-beta) dehydrogenase (HSD17B11) catalyzes the conversion of 5α-androstan-3α,17β-diol into androsterone suggesting that it may play an important role in androgen metabolism. We previously described that overexpression of C/EBPα or C/EBPβ induced HSD17B11 expression in HepG2 cells but this process was not mediated by the CCAAT boxes located within its proximal promoter region. Here, we study HSD17B11 transcriptional regulation in prostate cancer (PC) cells. Transfection experiments showed that the region -107/+18 is sufficient for promoter activity in PC cells. Mutagenesis analysis indicated that Sp1 and C/EBP binding sites found in this region are essential for promoter activity. Additional experiments demonstrated that ectopic expression of Sp1 and C/EBPα upregulated HSD17B11 expression only in PC cell lines. Through DAPA and ChIP assays, specific recruitment of Sp1 and C/EBPα to the HSD17B11 promoter was detected. These results show that HSD17B11 transcription in PC cells is regulated by Sp1 and C/EBPα.

Mots clés: Gene regulation; HSD17Bs; C/EBPα; Sp1; Transcription Factors.; Transcription Factors

Domaines: Biochimie, Biologie Moléculaire

Mirja Rotinen, Joaquín Villar, Jon Celay, Irantzu Serrano, Vicente Notario, et al.. Transcriptional Regulation of Type 11 17β-Hydroxysteroid Dehydrogenase Expression in Prostate Cancer Cells. Molecular and Cellular Endocrinology, 2011, ⟨10.1016/j.mce.2011.03.015⟩. ⟨hal-00708529⟩